Q1 2018 13F Holders as of 3/31/2018
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
87M
-
Number of holders
-
97
-
Total 13F shares, excl. options
-
23.6M
-
Shares change
-
+4.06M
-
Total reported value, excl. options
-
$442M
-
Value change
-
+$77.4M
-
Number of buys
-
61
-
Number of sells
-
-29
-
Price
-
$18.75
Significant Holders of Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA) as of Q1 2018
105 filings reported holding KURA - Kura Oncology, Inc. - Common Stock, par value $0.0001 per share as of Q1 2018.
Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA) has 97 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 23.6M shares
of 87M outstanding shares and own 27.09% of the company stock.
Largest 10 shareholders include FMR LLC (4.43M shares), EcoR1 Capital, LLC (3.77M shares), GREAT POINT PARTNERS LLC (2.38M shares), BlackRock Inc. (1.6M shares), BVF INC/IL (1.35M shares), Partner Fund Management, L.P. (1.34M shares), VANGUARD GROUP INC (1.25M shares), Boxer Capital, LLC (845K shares), STATE STREET CORP (779K shares), and Sio Capital Management, LLC (657K shares).
This table shows the top 97 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.